| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.891 | 38.427 | 23.379 | 21.884 | 27.971 | 31.996 | 35.969 | 47.492 | 10.420 |
| Total Income - EUR | - | 20.906 | 38.461 | 23.401 | 21.893 | 27.976 | 41.261 | 35.969 | 47.492 | 10.479 |
| Total Expenses - EUR | - | 2.482 | 5.686 | 5.961 | 6.979 | 8.086 | 7.771 | 10.718 | 19.864 | 11.736 |
| Gross Profit/Loss - EUR | - | 18.424 | 32.774 | 17.440 | 14.914 | 19.890 | 33.490 | 25.251 | 27.629 | -1.256 |
| Net Profit/Loss - EUR | - | 17.797 | 31.621 | 16.738 | 14.257 | 19.100 | 32.252 | 24.338 | 27.154 | -1.872 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Snrmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16.189 | 12.174 | 7.591 | 3.331 | 0 | 21.850 | 15.174 | 9.164 | 2.015 |
| Current Assets | - | 11.819 | 19.745 | 9.360 | 11.145 | 19.149 | 10.450 | 9.358 | 19.403 | 10.279 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 9.613 | 15.084 | 4.513 | 680 | 1.215 | 634 | 0 | 5.852 | 503 |
| Cash | - | 2.206 | 4.661 | 4.848 | 10.465 | 17.935 | 9.817 | 9.358 | 13.550 | 7.766 |
| Shareholders Funds | - | 17.841 | 31.664 | 16.781 | 14.308 | 19.149 | 32.301 | 24.387 | 27.202 | -1.823 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.167 | 255 | 170 | 167 | 0 | 0 | 145 | 1.365 | 14.117 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Snrmed Srl